صفحه اصلی مجموعه  Hematology Oncology Clinical of North America

RSS Feed


PreviewIssue DateTitleContributor(s)
2016 HOCNA Volume 30 Issue 3 June (9).pdf.jpg2016Management of T h ro m b o t i c M i c ro a n g i o p a t h i c Hemolytic Anemias with T h e r a p e u t i c Pl a s m a E x c h a n g e When It Works and When It Does NotMehmood, Tahir; Taylor, Michelle; Winters, Jeffrey L
2016 HOCNA Volume 30 Issue 3 June (6).pdf.jpg2016Red Blood Cell Antibodies in Hematology / Oncology P a t ients Interpretation of Immunohematologic Tests and Clinical Significance of Detected AntibodiesHendrickson, Jeanne E
2016 HOCNA Volume 30 Issue 3 June (3).pdf.jpg2016P l a t e l e t Tr a n s f u s i o n s in Patients with H y p o p ro l i f e r a t i v e T h ro m b o c y t o p e n i aCrighton, Gemma L; Estcourt, Lise J; Wood, Erica M; Stanworth, Simon J
2016 HOCNA Volume 30 Issue 3 June (4).pdf.jpg2016Assessing the Rationale a n d E ffe c t i v e n e s s o f F ro z e n P l a s m a Tra n s f u s i o n s Frozen plasma Hemostasis Bleeding Prophylaxis AppropriatenessReview, An Evidence-based; Tinmouth, Alan
2016 HOCNA Volume 30 Issue 3 June (2).pdf.jpg2016R e d B l o o d C e l l Tr a n s f u s i o n Strategies in Adult and Pediatric Patients with Malignancy Randomized clinical trials RBC transfusion Malignancy BleedingRoubinian, Nareg; Carson, Jeffrey L
2016 HOCNA Volume 30 Issue 3 June (5).pdf.jpg2016Autologous Stem Cell Mobilization and CollectionHsu, Yen-michael S
2016 HOCNA Volume 30 Issue 3 June (7).pdf.jpg2016Modifications to Blood Components When to Use them and What is the Evidence ?Gehrie, Eric A
2016 HOCNA Volume 30 Issue 3 June (8).pdf.jpg2016Management of the Platelet Refractory PatientForest, Stefanie K
2016 HOCNA Volume 30 Issue 3 June (17).pdf.jpg2016Transfusion MedicineHendrickson, Jeanne E; Tormey, Christopher A; Roubinian, Nareg; Carson, Jeffrey L
2016 HOCNA Volume 30 Issue 1 February (6).pdf.jpg2016S y ste mic Th er ap i es f o r A d v a n c e d G a s t ro i n t e s t i n a l C a rc i n o i d Tu m o r sMulvey, Claire K
2016 HOCNA Volume 30 Issue 1 February (9).pdf.jpg2016S y ste mic Th er ap i es f o r A d v a n c e d P a n c re a t i c N e u ro e n d o c r i n e Tu m o r sRaj, Nitya; Reidy-lagunes, Diane
2016 HOCNA Volume 30 Issue 2 April (11).pdf.jpg2016T h e Pres e n t a n d F u t u re G l o b a l B u rd e n o f t h e I n h e r i t e d D i s o rd e r s o f HemoglobinPiel, Frédéric B
2016 HOCNA Volume 30 Issue 2 April (10).pdf.jpg2016I ro n D e f i c i e n c y A n e m i a Problems in Diagnosis and Prevention at the Population Level Iron Hepcidin Anemia Public health Children Infection MalariaPasricha, Sant-rayn; Drakesmith, Hal
2016 HOCNA Volume 30 Issue 1 February (7).pdf.jpg2016B ro n c h i a l a n d Th y m i c C a rc i n o i d Tu m o r s Bronchial Thymic Neuroendocrine Typical carcinoid Atypical carcinoidLitvak, Anya; Pietanza, M Catherine
2016 HOCNA Volume 30 Issue 2 April (12).pdf.jpg2016S i c k l e C e l l D i s e a s e i n Su b - Saharan Africa Sickle cell disease Children Public health Bacteremia Sub-Saharan AfricaWilliams, Thomas N
2016 HOCNA Volume 30 Issue 2 April (13).pdf.jpg2016D e h y d ro g e n a s e D e f i c i e n c yLuzzatto, Lucio; Nannelli, Caterina
2016 HOCNA Volume 30 Issue 1 February (8).pdf.jpg2016Surgical Management of P a n c re a t i c N e u ro e n d o c r i n e Tu mo r sClancy, Thomas E
2016 HOCNA Volume 30 Issue 2 April (1).pdf.jpg2016Preface Global HematologyRoberts, David J; Weatherall, Frcpath David J
2016 HOCNA Volume 30 Issue 3 June (11).pdf.jpg2016Management of Patients with Sickle Cell Disease U s i n g Tr a n s f u s i o n T h e r a p y Guidelines and ComplicationsChou, Stella T; Fasano, Ross M
2016 HOCNA Volume 30 Issue 3 June (1).pdf.jpg2016Pathogen Inactivation Tec h n o l o g i e s The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety RiskDevine, Dana V; Schubert, Peter

مرور
Type of Materials
Date issued
???jsp.search.facet.refine.Month???